About EBR Systems
EBR Systems (ASX:EBR) is a medical device company that develops and commercialises the WiSE CRT™ System, the world's first and only leadless cardiac pacing device for heart failure. Leadless CRT is a minimally invasive therapy that can be implanted without the need for wires or leads, and it offers a number of advantages over traditional CRT devices, including reduced risk of infection and lead-related complications. EBR Systems' operations are focused on the commercialization of the WiSE CRT System in the United States, the world's largest market for CRT devices. The company is currently conducting a pivotal clinical trial to support FDA approval of the WiSE CRT System, and it expects to launch the device commercially in the United States in 2024.
Snapshot
Operations
Produtos e/ou serviços de EBR Systems
- WiSE Cardiac Resynchronization Therapy System: This system uses a proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart. This aims to address limitations and complications associated with traditional methods that use leads.
- WiSE (Wireless Stimulation Endocardially): technology to deliver electrical stimulation directly to the inside of the left ventricle of the heart without implanted leads, aiming to address complications associated with traditional methods.
- Research and Development: EBR invests in ongoing research and development to improve the WiSE system and explore its potential applications for other cardiac rhythm management needs.
- Regulatory Activities: The company pursues regulatory approvals for the WiSE system in different regions to enable broader commercialisation.
- Manufacturing and Distribution Partnerships: EBR works with partners for manufacturing and distribution of the WiSE system as they scale up operations.
equipe executiva do EBR Systems
- Mr. Allan Roger Will B.S., M.S.Executive Chairman
- Mr. John Graham McCutcheon B.A., M.B.A.President, CEO & Director
- Mr. Gary W. Doherty B.S.Chief Financial Officer
- Mr. Michael Hendricksen B.S., M.S.Chief Operating Officer
- Dr. N. Parker Willis B.S., M.S., Ph.D.Chief Technology Officer
- Mr. Andrew Shute B.S.Senior Vice President of Business Development
- Ms. Madhuri Bhat B.A., M.B.A.Chief Regulatory Officer
- Dr. Spencer H. Kubo M.D.Chief Medical Officer
- Mr. Erik StrandbergChief Commercial Officer
- Mr. John H. SellersSecretary